Ruth Thieroff-Ekerdt, MD, serves as Executive Vice President Clinical Development at Cambrian BioPharma, a company with a vision to extend healthspan by developing therapeutics that target molecular and cellular processes of aging. Prior to Cambrian, she was Chief Medical Officer at Sojournix, and Acting CMO/Scientific Advisor at Forendo/Organon. She also served as Chief Medical Officer at Aptalis, Strongbridge, and Kaleido, and held R&D positions of increasing responsibility at Bayer. She graduated as MD and Dr. med. from the Free University Berlin and specialized in Pharmacology and Clinical Pharmacology. She has over 30 years of experience in pharmaceutical R&D in all stages of discovery, development, and commercialization, with a successful track record of leading translational and development programs, submissions, and product launches in EU and US in diverse therapeutic areas and technologies. She served as expert for the European Innovative Medicine Initiative and on the Scientific Advisory Board for Chr. Hansen.